---
title: "Sellas Life Sciences 集团第一季度亏损收窄"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/286156649.md"
description: "2026 年 5 月 12 日下午 4:44（东部夏令时间）——SELLAS Life Sciences Group（SLS）在周二晚间报告了第一季度每股摊薄亏损 0.05 美元，较去年同期的 0.07 美元亏损有所收窄。根据 FactSet 的调查，两位分析师预计亏损为 0.06 美元。第一季度末现金及现金等价物为 1.071 亿美元，而第四季度末为 7180 万美元。该公司股票在盘后交易中上涨超过 12%。MT Newswires 不提供投资建议。未经授权的复制严格禁止"
datetime: "2026-05-12T20:44:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286156649.md)
  - [en](https://longbridge.com/en/news/286156649.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286156649.md)
---

# Sellas Life Sciences 集团第一季度亏损收窄

04:44 PM EDT, 05/12/2026 (MT Newswires) -- SELLAS Life Sciences Group ( SLS ) reported a Q1 loss late Tuesday of $0.05 per diluted share, narrowing from a loss of $0.07 a year earlier.

Two analysts polled by FactSet expected a loss of $0.06.

Cash and cash equivalents were $107.1 million at the end of Q1, compared with $71.8 million at the end of Q4.

Shares of the company rose more than 12% in after-hours activity.

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

### 相关股票

- [SLS.US](https://longbridge.com/zh-CN/quote/SLS.US.md)
- [FDS.US](https://longbridge.com/zh-CN/quote/FDS.US.md)

## 相关资讯与研究

- [Top 10 美股跌幅（5月21日）](https://longbridge.com/zh-CN/news/287277374.md)
- [随着白血病研发管线的推进，Sellas Life Sciences 即将迎来关键试验结果](https://longbridge.com/zh-CN/news/286279161.md)
- [BRIEF: Niu Technology’s loss widens on growing expenses](https://longbridge.com/zh-CN/news/286932120.md)
- [VerifyMe 第一季度收入因失去合作伙伴而下滑](https://longbridge.com/zh-CN/news/286562849.md)
- [在 GPGI 出现季度净亏损的剧烈波动后，评估其估值](https://longbridge.com/zh-CN/news/287251190.md)